Nalpropion Pharmaceuticals, Inc., the maker of CONTRAVE, provides this list to help patients find healthcare professionals who have experience with prescription weight loss medications, including CONTRAVE. You are ultimately responsible for the selection of a healthcare professionals and it is an important decision that you should consider.
. NN YBupropion/naltrexone is a used for in those that are either or with some weight-related illnesses. It combines low doses of. Both drugs have individually shown some evidence of effectiveness in weight loss, and the combination has been shown to have some synergistic effects on weight.In September 2014, a formulation of the drug was approved for marketing in the United States under the brand name Contrave.
The combination was subsequently approved in the in the spring of 2015, where it is sold under the name Mysimba. It was approved in Canada under the Contrave brand name in 2018. ^ (Press release). 10 September 2014. Plodkowski RA, Nguyen Q, Sundaram U, Nguyen L, Chau DL, St Jeor S (April 2009).
'Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity'. Expert Opinion on Pharmacotherapy. 10 (6): 1069–81.
Tek C (2016). Patient Preference and Adherence. 10: 751–9. ^ Orexigen Therapeutics, Inc. (March 26, 2015). Retrieved 28 March 2015. ^.
Archived from on 2014-11-02. Retrieved 2 November 2014. Greenway FL, Whitehouse MJ, Guttadauria M, Anderson JW, Atkinson RL, Fujioka K, et al. (January 2009).
'Rational design of a combination medication for the treatment of obesity'. 17 (1): 30–9.
Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, et al. 21 (5): 935–43. 29 October 2009. Archived from on 2 November 2009. Orexigen Therapeutics, Inc.
Retrieved 2016-12-29.,. Retrieved 2016-12-29. Silverman E (2015-05-12). Retrieved 2016-12-29. ^ Osborne S (May 8, 2015). Seeking Alpha (blog).
Retrieved May 9, 2015. Grover N (September 10, 2014). Business Insider. Retrieved March 28, 2015.
Osborne S (December 12, 2014). Seeking Alpha (blog). Retrieved March 28, 2015. Agonists (abridged; see for a full list):.
PAMs:. Antagonists:. Unknown/unsorted:.